NASDAQ : DRUG
-$1.37 (-1.84%)
12
1
$109.33K
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | other: Former 10% Owner | 2026-04-28 | S-Sale | 89.5 | 2026-04-30 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-11-04 | P-Purchase | 21.7 | 2024-11-06 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-16 | P-Purchase | 25.222 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-16 | P-Purchase | 24.03 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-16 | P-Purchase | 23.215 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | P-Purchase | 12.3513 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | P-Purchase | 11.7169 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | P-Purchase | 9.2624 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | P-Purchase | 8.804 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | P-Purchase | 7.3052 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | P-Purchase | 6.4247 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | P-Purchase | 5.924 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | P-Purchase | 4.5304 | 2024-10-17 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-10-15 | 0 | 2024-10-17 |